UK markets closed

ATOS Sep 2024 1.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.45000.0000 (0.00%)
At close: 02:49PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Atossa Set to Join Russell 3000® Index Effective June 28, 2024

    SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected upcoming inclusion in the Russell 3000® Index, according to preliminary Russell reconstruction information posted on the FTSE Russell website. The newly reconstructed index will take effect after the market closes on June 28, 2024. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical nee

  • Zacks

    Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

    Here is how Atossa Genetics Inc. (ATOS) and Ocugen (OCGN) have performed compared to their sector so far this year.

  • GlobeNewswire

    Atossa to Present at the Sidoti Small-Cap Investor Conference

    SEATTLE, June 05, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the Company will present at the Sidoti Small-Cap Investor Conference being held June 12-13, 2024. The presentation by Steven Quay, M.D., Ph.D., Atossa’s President and Chief Executive Officer, will take place on Thursday, June 13 at 9:15 am eastern time. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unm